Top 10 Medical Device Angel Investors in Singapore (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Paul Buchheit
Angel
|
2 | United States, Canada, India | Seed, Series A, Angel | Software, E-Commerce, Health Care | $100k–$13M |
|
Matt Cutts
Angel
|
1 | United States, Canada, Mexico | Seed, Angel, Series A | SaaS, Health Care, Medical | $493k–$2.8M |
|
Johannes Hille
Angel
|
1 | Singapore | Seed | Medical, Health Care, Biotechnology | |
|
Jack Wang
Angel
|
1 | Singapore | Seed | Fertility, Biotechnology, Medical Device | |
|
Benjamin Boyer
Angel
|
1 | United States, China, Singapore | Series C, Seed, Series B | Software, Internet, E-Commerce | $1.2M–$110M |
|
Binny Bansal
Angel
|
1 | India, United States, Singapore | Seed, Series A | Software, Internet, E-Commerce | $415k–$18M |
|
Eric Urhane
Angel
|
1 | United States, Mexico, Singapore | Seed, Angel | Software, Health Care, Biotechnology | $1.1M–$1.9M |
|
Frederik Vandermarlie
Angel
|
1 | Belgium, Singapore | Seed | Medical, Legal Tech, Health Care | $2.2M–$4M |
|
Avi Reichental
Angel
|
1 | United States, Israel, Singapore | Seed, Angel | 3D Printing, Health Care, 3D Technology | $495k–$3M |
|
Feng Hu
Angel
|
1 | United States, India, Singapore | Seed, Pre-Seed, Convertible Note | Communities, Mobile Apps, CRM | $1.3M–$1.4M |
| Access all 15 angel investors in Singapore Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States, Canada, India
Investor stats
- Total investments: 152
- Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$13M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- BuildForever — BuildForever build products that feel personal, magical and deeply human.
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his
Show more...Investment focus
- Industry: SaaS, Health Care, Medical
- Stage:Seed, Angel, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 11
- Round size: Seed $493k–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Meter Feeder — Easily pay for parking through MeterFeeder
Johannes Hille
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Jack Wang
Show more...Investment focus
- Industry: Fertility, Biotechnology, Medical Device
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.
Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000.Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments.Ben holds an M.B.A. from Stanford Graduate Schoolof Business and a B.S. in human and organizational development from Vanderbilt University.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Series C, Seed, Series B
- Geography: United States, China, Singapore
Investor stats
- Total investments: 22
- Round size: Seed $1.2M–$4.4M; Series B $12M–$50M; Series C $10M–$110M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Kangaroo — No hidden upfront costs or astronomical monthly monitoring fees. Our plans are contract-free, flexible and affordable. We even help you earn cash back on your insurance policy! Our sensors are batteries-included, peel-and-stick, app-controlled easy. Choose a free plan or professionally monitored plan for only $99/yr.
- People.ai — Uncover the Fastest Path to Revenue
- Triparound — Discover our guest experience platform for hotels and vacation rental managers. Run smoother operations, impress guests, and boost profits.
Binny Bansal is an Indian software engineer and Internet entrepreneur. In 2007 he co-founded the e-commerce platform Flipkart with Sachin Bansal (not related) and was serving as the Chief Operating Officer until 11 January 2016 and was promoted to Chief Executive Officer. In January 2017 he was promoted to Group CEO of Flipkart. Binny is fromChandigarh and graduated from the Indian Institute of Technology Delhi with a degree in Computer Science and Engineering.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Seed, Series A
- Geography: India, United States, Singapore
Investor stats
- Total investments: 108
- Round size: Seed $415k–$5.8M; Series A $3M–$18M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Curefoods — Curefoods democratizes access to food on a sustainable basis. They focus on operations management for cloud kitchens and the online food ordering market.
- Superplum — Superplum addresses Indian agriculture’s supply chain problems by designing, building, and digitizing the farm-to-store network. Consumers get fresh and fully traceable food that is free of pesticides and farmers get a better deal.
- Equal Identity — Equal Identity operates as an ID-sharing platform.
Eric Urhane
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Angel
- Geography: United States, Mexico, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Frederik Vandermarlie
Show more...Investment focus
- Industry: Medical, Legal Tech, Health Care
- Stage:Seed
- Geography: Belgium, Singapore
Investor stats
- Total investments: 2
- Round size: Seed $2.2M–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- X-ZELL — Early, pain-free cancer cell detection
- Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.
Avi Reichental is the current Co-Founder & Chairman of ParaMatters. He previously worked at Singularity University as a Core Faculty.
Show more...Investment focus
- Industry: 3D Printing, Health Care, 3D Technology
- Stage:Seed, Angel
- Geography: United States, Israel, Singapore
Investor stats
- Total investments: 9
- Round size: Seed $495k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- NXT Factory — Development a groundbreaking beam delivery system, that converts a single laser into several million microlasers, without power degradation.
- ParaMatters — Introducing 3D Printing Software that saves engineers time and effort by automating the process of creating conformal, single-zone lattices.
- Centaur Analytics, Inc. — Centaur Analytics is a industrial data and IoT analytics platform for post-harvest quality monitoring.Centaur Analytics use data science and sensors to monitor and predict product quality and safety for grains, like malting barley, wheat, and other commodities.
Feng Hu
Show more...Investment focus
- Industry: Communities, Mobile Apps, CRM
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, India, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $1.3M–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
- DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
- Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.
Medical Device Angel investor funding in Singapore at a glance
Stats across 11 deals from 15 investors.
Access all 15 angel investors in Singapore Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Angel Investors in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 15 angel investors investing in Singapore Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!